Form 4: GoodRx Holdings Executive Reports Stock Transaction
Insider Transaction (Form 4)
Justin Fengler, See Remarks of GoodRx Holdings, Inc., reported multiple transactions in common stock on September 15, 2026.
Summary
- Option exercise/conversion: acquired 2,335 Class A Common Stock on September 15, 2026; holds 53,111 after (Direct).
- Tax/exercise-price withholding: disposed of 1,024 Class A Common Stock at $3.56 ($3,645) on September 15, 2026; holds 52,087 after (Direct).
- Option exercise/conversion: acquired 752 Class A Common Stock on September 15, 2026; holds 52,839 after (Direct).
- Tax/exercise-price withholding: disposed of 330 Class A Common Stock at $3.56 ($1,175) on September 15, 2026; holds 52,509 after (Direct).
- Option exercise/conversion: disposed of 2,335 Restricted Stock Unit on September 15, 2026; holds 14,006 after (Direct).
- Option exercise/conversion: disposed of 752 Restricted Stock Unit on September 15, 2026; holds 9,023 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Justin Fengler — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Class A Common Stock | 2,335 | — | — | 53,111 |
| 2026-09-15 | Tax/exercise-price withholding | Class A Common Stock | 1,024 | $4 | $3.6K | 52,087 |
| 2026-09-15 | Option exercise/conversion | Class A Common Stock | 752 | — | — | 52,839 |
| 2026-09-15 | Tax/exercise-price withholding | Class A Common Stock | 330 | $4 | $1.2K | 52,509 |
| 2026-09-15 | Option exercise/conversion | Restricted Stock Unit | 2,335 | — | — | 14,006 |
| 2026-09-15 | Option exercise/conversion | Restricted Stock Unit | 752 | — | — | 9,023 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (2,335 shares) |
| 2026-09-15 | Tax/exercise-price withholding (1,024 shares) |
| 2026-09-15 | Option exercise/conversion (752 shares) |
| 2026-09-15 | Tax/exercise-price withholding (330 shares) |
| 2026-09-15 | Option exercise/conversion (2,335 shares) |
| 2026-09-15 | Option exercise/conversion (752 shares) |
Keywords
insider transaction, Form 4, GDRX, GoodRx Holdings, Inc., neutral, Justin Fengler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.